U

Unilabs

www.unilabs.com link_icon

Unilabs Company Research Report



Company Overview



Name and Mission


  • Company Name: Unilabs

  • Mission: Unilabs aims to be at the heart and start of all effective treatment decisions.


Founding Information


  • Founded: 1987

  • Founders: Unilabs was initially established through the takeover of three Swiss labs previously owned by US-based Corning.


Key People


  • Chief Executive Officer: Marc Engel

  • Chief Market Officer: Alessandre Keller

  • Chief Medical Officer: Thomas Lindahl

  • Chief Financial Officer: Britt Hendriksen

  • General Counsel and Chief Compliance Officer: Robert Abbott

  • Chief Data and Information Officer: Robin Dargue

  • Chief Human Resources Officer: Shalinee Basak

  • Chief Transformation Officer: Steffen Risager


Headquarters


  • Location: No specific headquarters location is mentioned in the provided data.


Number of Employees


  • Employees: More than 13,500


Revenue


  • Annual Sales: Approximately €1.6 billion


Company Recognition


  • Known For: Unilabs is recognized as one of the largest diagnostic providers in Europe, the only provider offering laboratory, imaging, and pathology specialties within one group.


Products



Product Offerings


  • Laboratory Medicine: Comprehensive laboratory tests across various medical conditions.

  • Cellular Pathology: Detailed analysis and diagnostics of cell and tissue samples.

  • Medical Imaging: Advanced imaging services for accurate diagnostics.

  • Specialty Testing: Targeted tests for specific conditions and diseases.

  • Drug Development Services: Support for clinical trials and drug development processes.

  • Reproductive Medicine and Genetics: Tests and diagnostics in reproductive health and genetics.


High-Level Product Descriptions and Key Features


  • Laboratory Medicine: Known for conducting a high volume of tests, with over 221 million annual laboratory tests.

  • Medical Imaging: Offers more than 5 million annual imaging examinations, supported by 180+ imaging centers.

  • Pathology Services: Integration with comprehensive medical disciplines for holistic diagnostics.

  • Specialty Testing and Drug Development: Extensive experience with over 3000 studies and more than 30 years in clinical trials.

  • Reproductive Medicine and Genetics: Cutting-edge offerings in genetic medicine and pathology.


Recent Developments



New Product Launches and Innovations


  • Innovation in Molecular Testing: Groundbreaking advancements in molecular profiling for cancer diagnosis.


New Features and Partnerships


  • AI Integration in Radiology: Using AI for enhancing detection of over 100 conditions including brain aneurysms and tumors.

  • Global Partnership with C2N Diagnostics: Expansion of C2N’s Alzheimer’s Disease blood tests across Europe and beyond.


Organizational Changes


  • Leadership Appointment: Thomas Lindahl appointed as Chief Medical Officer in July 2024.


Research and Development


  • Focus on Genetic Diagnostics: Emphasis on advancing genetic diagnostics in various medical domains including obstetrics and oncology.


Recent Publications and Campaigns


  • Breast Cancer Awareness Collaboration: Detailed insights on breast cancer signs in partnership with Dr. Hanna Bjerke.

  • Alzheimer’s and Oncogenetics Studies: Engaging discussions featuring Unilabs' experts on Alzheimer’s and genetic oncological diseases.


This report encapsulates key information about Unilabs, showcasing their robust offering in diagnostic services, leadership structure, and continued innovations in medical diagnostics.